Shirin Khorsandi

16PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Industrial and organisational psychology (incl. human factors)Cancer diagnosisMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 14, 2025
Design and Evaluation of RNA Aptamer-Mediated Delivery of C/EBPβ siRNA for Oncological Therapy.

D Vasconcelos, M H Sodergren, V Reebye

|Feb 04, 2023
Outcomes after liver transplantation using deceased after circulatory death donors: A comparison of outcomes in the UK and the US.

Tommy Ivanics, Marco P A W Claasen, Madhukar S Patel

|Apr 23, 2022
Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer.

Roger Carles-Fontana, Nigel Heaton, Elena Palma

|Sep 23, 2021
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets.

Shirin Elizabeth Khorsandi, Arran D Dokal, Vinothini Rajeeve

|Mar 26, 2021
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs.

Henry Gerdes, Pedro Casado, Arran Dokal

|Nov 22, 2020
Comparable graft survival is achievable with the usage of donation after circulatory death liver grafts from donors at or above 70 years of age: A long-term UK national analysis.

Emmanouil Giorgakis, Shirin E Khorsandi, Amit K Mathur

Pageof 3